Glutathione S-transferases (GSTs) are a family of detoxification isoenzymes present in different tissues including the testis and that conjugate many toxic substrates to glutathione. Among these substrates are carcinogens, mutagens and products of oxidative processes. In the present report we show that GST␣ is expressed in somatic testicular Leydig cells and Sertoli cells. GST␣ expression in Sertoli cells is under the hormonal control of FSH, testosterone, and estradiol. In Leydig cells, immunoreactive GST␣ was present at the neonatal, pubertal, and adult periods. In Sertoli cells, GST␣ was predominant in pubertal and adult testes (but not in neonatal testes), suggesting that its expression is controlled by gonadotropins. The regulatory action and the mechanisms of action of FSH and testosterone on GST␣ mRNA and protein levels were studied by using a model of primary cultures of porcine testicular Sertoli cells. FSH increased GST␣ mRNA levels in a dose-dependent manner (ED 50 ‫؍‬ 18.5 nm/ml) with a maximal effect observed after 48 h of exposure (a 3-fold increase; P Ͻ 0.001). In addition, FSH increased GST␣ protein, which was detected as a doublet of 28 kDa. Treatment with testosterone enhanced GST␣ mRNA levels in a dose-dependent (ED 50 ‫؍‬ 1.4 ng/ml) and time-dependent manner with a maximal effect delayed at 8 h of exposure (a 2-fold increase; P Ͻ 0.001). Similarly, Sertoli cell treatment with testosterone metabolites, dihydrotestosterone (DHT) and estradiol, led to an increase in GST␣ mRNA levels. Because stimulatory effects of FSH and androgens were also observed on GST␣ protein, we therefore had to determine whether the different hormones were affecting GST␣ gene transcriptional activity, or GST␣ mRNA stability, or both. FSH and 8-Br-cAMP (but not testosterone) increased the stability of GST␣ mRNA. The effects of FSH and testosterone on GST␣ protein were additive, confirming that both hormones act through distinct mechanisms on the expression of the enzyme. Taken together, the present observations indicate that Sertoli cell GST␣ is targeted by FSH, testosterone, and its metabolites, and they reinforce the concept that Sertoli cells exert a protective role and are under endocrine control to ward against toxic agents in the context of Sertoli-germ cell interactions during spermatogenesis.
INTRODUCTION
Glutathione S-transferases (GSTs) (EC 2.5.1.18) are known as a large family of abundant enzymes in most organisms. GSTs are detoxification enzymes that catalyze the conjugation of a wide range of electrophilic compounds to glutathione (GSH), a tripeptide found in all mammalian cells [1] [2] [3] . These compounds include carcinogens, environmental pollutants, anticancer agents, antibiotics, and products of oxidative processes that cause DNA and protein damage [4, 5] . Both cytosolic and microsomal forms of GSTs have been identified [6] . Cytosolic GSTs are homodimers or heterodimers, they share some homology, and they possibly evolved from a common ancestral gene [7] . GST isoenzymes exhibit distinct structural and biochemical characteristics that determine their relative activity toward different substrates [8] .
Mammalian GSTs have been classified into five distinct gene families: alpha, mu, pi, sigma, and theta. The alpha gene family contains the Ya, Yc, and Yk subunits. The mu gene family consists of Yb1, Yb2, Yb3, Yb4, Yn, and Y0 subunits. The pi gene family is made up of the Yf subunit. New subunits are being added to the families on a regular basis.
GST activity is regulated at the transcriptional level by a variety of compounds, including phenobarbital [9] and antioxidants [10] . Distribution of GST isoenzymes in different tissues is not uniform, and mammalian organs show a marked diversity in their GST content. The testis has high levels of GSTs [11, 12] . Indeed, different GST isoenzymes have been identified in the male gonad. Specifically, GST␣ [13] [14] [15] and GST [16] have been identified in testicular somatic cells and particularly in Leydig and Sertoli cells. GST was shown to be expressed in somatic and germ cells [17] [18] [19] [20] [21] . In addition to its role as a phase II detoxification enzyme involved in the conjugation of electrophilic xenobiotics such as carcinogens and mutagens to the endogenous nucleophile GSH, particularly in the testis, GST␣ also contributes to a major portion of the selenium-independent glutathione peroxidase (GPx) activity toward phosphatidylcholine hydroperoxide [7, [22] [23] [24] . Therefore, GST␣ may be necessary for protecting this tissue from reactive oxygen species-induced damage.
The importance of GSTs in the protection against oxidative stress in testis is underscored by recent studies showing that when GST activity is inhibited, products of lipid peroxidation accumulate, resulting in germ cell apoptosis [25] . More recently, these observations were further strengthened by data demonstrating that overexpression of GSTA2-2 (a member of the GST␣ class) in K562 cells attenuates the cytotoxic effect of H 2 O 2 and other oxidants, and protects against H 2 O 2 -induced apoptosis by blocking caspase 3 activation [26] . Finally, in addition to protecting the germ cells from the toxic effects of carcinogens and mutagens and from free radical damage [16, 27] , GSTs may also exert some specific effects in the male reproductive function. Indeed, GST isoenzymes exhibit a steroid binding activity and seem to be involved in male fertility, specifically in the gamete interactions [28] .
Spermatogenesis is highly dependent on Sertoli cells [29] [30] [31] , which are under direct endocrine control [30] [31] [32] . Endocrine regulation allows Sertoli cells to develop and reorganize, and to generate the hematotesticular barrier through their tight junction complexes and to provide nutrients and regulatory factors to the germ cells. This timemodeling process and the production of Sertoli cell factors lead to the constitution of a specific biochemical and cytoarchitectural microenvironment in the adluminal compartment where germ cells will proliferate and differentiate. These different processes occur under the control of hormonally regulated Sertoli cell factors. Among the identified Sertoli cells factors are binding transport proteins, proteases and protease inhibitors, energy substrates such as lactate, local signaling molecules such as growth factors and cytokines [29] [30] [31] [32] , and hematotesticular barrier proteins such as claudin 11 [33] .
In the present study we examined whether the expression of testicular GSTs, and specifically those expressed in Sertoli cells, might be under hormonal control. We report that GST␣ expressed in Sertoli cells is under the regulatory control of FSH and testosterone and its two metabolites, dihydrotestosterone and estradiol.
MATERIALS AND METHODS

Materials
Dulbecco modified Eagle medium (DMEM)/Hams F12 medium and TRIzol were obtained from Life Technologies (Eragny, France). Collagenase/dispase was obtained from Roche (Mannheim, Germany). Testosterone, 17␤-estradiol, dihydrotestosterone, flutamide, 8-bromo adenosine 3Ј,5Ј-monophosphate (8-Br-cAMP), 5,6-dichlorobenzimidazole riboside (DRB), cycloheximide, 3-cyclohexylamino-1-propanesulfonic acid (CAPS), protease inhibitor cocktail, and BSA were purchased from Sigma Chemical Company (St. Louis, MO). Ovine FSH was kindly provided by Dr. A.F. Parlow of the U.S. Department of Agriculture, Agricultural Research Service, Animal Hormone Program (Beltsville, MD). ICI 182,780 was purchased from Tocris Cookson Inc. (Avonmouth Bristol, U.K.). Rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe was a generous donation by Dr. J.M. Blanchard (Faculty of Sciences, Montpellier, France). The rabbit polyclonal anti-human GST␣ antibody (NCL-GST␣) [34, 35] and Rp-adenosine-3Ј,5Ј-cyclic monophosphorothioate triethylamine salt (Rp-cAMPS) were purchased from Novocastra-TEBU (Le Perray en Yvelines, France). Peroxidase-conjugated goat anti-rabbit immunoglobulin G was obtained from COVALAB (Lyon, France). Antibody diluent was obtained from DAKO (Copenhagen, Denmark). The Ultravision Detection System was obtained from Lab Vision Corporation (Fremont, CA). The Bradford reagents and Pierce detection kit were purchased from Bio-Rad Laboratories, Inc. (Richmond, CA).
Sertoli Cell Isolation and Culture
Sertoli cells were isolated from immature porcine testes (2-3 wk old) using collagenase treatment as described by Mather and Phillips [36] . Briefly, the testes were decapsulated, minced, and washed in DMEM/Hams F12 (1:1) medium. After collagenase dissociation (0.4 mg/ml, 90-120 min at 32ЊC), cells were washed by mild centrifugation (200 ϫ g, 10 min). After 5 min of sedimentation, the tubules were recovered and washed 3 times by unit gravity in DMEM/Hams F12 medium. Contaminating interstitial Leydig cells were released after 20 min of treatment (at room temperature) with 20 ml of 1 M glycine, 2 mM EDTA, and 20 IU/ml desoxyribonuclease DNase in Ca 2ϩ , Mg 2ϩ -free PBS (pH 7.2). Tubules were then washed 3 times in DMEM/Hams F12 medium by gravity before incubation in DMEM/Hams F12 medium containing collagenase (0.4 mg/ ml) and DNase (0.05 mg/ml) for 30 min at 32ЊC. The supernatants containing the peritubular myoid cells were removed, and the sedimented tubules were treated again as described above with collagenase (0.4 mg/ ml, 30 min, 32ЊC) to isolate Sertoli cells. This procedure led to a purified Sertoli cell population free from contamination by either Leydig cells or germ cells [37] and contained 2%-5% peritubular myoid cells. Sertoli cells were further washed several times by gravity in DMEM/Hams F12. Cells were counted in a Coulter counter (Coulter Electronics, Margency, France), plated in Falcon (Los Angeles, CA) 60-mm Petri dishes (5 ϫ 10 6 cells/dish), and cultured at 32ЊC in a humidified atmosphere of 5% CO 2 , 95% air in DMEM/Hams F12 (1:1) medium containing sodium bicarbonate (1.2 mg/ml), 15 mM HEPES, and gentamycin (20 g/ml). This medium was supplemented with transferrin (5 g/ml), insulin (2 g/ml), and tocopherol (10 g/ml). The culture medium was changed every 2 days and the experiments were carried out in the 2 wk following cell preparation, during which the cultured Sertoli cells maintain their specific activity.
Preparation of Total RNA and Northern Blot Analysis
To prepare the GST␣ probe, approximately 600 ng of DNA were amplified by polymerase chain reaction (PCR). PCR amplification of the GST␣ cDNA was carried out using the following primers (Genset SA, Paris, France): forward, 5Ј-GCTGGCCAACTTCCCTCTGC-3Ј and reverse, 5Ј-TGCGTGCGAAAACAAAAT-3Ј, designed to amplify a sequence of 331 base pairs (bp). PCR cycles consisted of initial denaturation of mixed PCR without Taq polymerase at 94ЊC for 5 min. A total of 30 PCR cycles followed the addition of Taq polymerase. Each cycle involved 1 min of denaturation at 92ЊC, 1 min of primer annealing at 63ЊC, and 1 min of elongation at 70ЊC. The 30 cycles were followed by 5 min at 70ЊC. The PCR products were separated by electrophoresis in a 1% agarose gel and analyzed after ethidium bromide staining and UV illumination. GST␣ cDNA was purified and then labeled with 50 Ci of ([␣-32 P]dCTP) using a random primed DNA labeling kit.
Total RNAs from cells in culture were prepared using TRIzol, a monophasic solution of phenol and guanidine isothiocyanate. This reagent is an improvement over the single-step RNA isolation method developed by Chomczynski and Sacchi [38] . Briefly, cells were lysed by adding 1 ml of TRIzol reagent and passing the cell lysate through a pipette several times. The homogenized samples were incubated for 5 min to permit the complete dissociation of nucleoprotein complexes. Chloroform (200 l) was then added. After centrifugation the aqueous phase was precipitated with isopropanol (500 l), and pellets were washed with 70% ethanol. After solubilization in diethyl pyrocarbonate (DEPC) treated water, the amount of RNA was estimated by spectrophotometry at 260 nm. About 10 g of total RNAs, denatured for 15 min at 65ЊC in the presence of 2.2 M formaldehyde, 12.5 M formamide, and 1ϫ 3-N-morpholino propanesulfonic acid (MOPS) were size-fractionated by electrophoresis on 1.2% agarose, 2.2 M formaldehyde gels. After migration in 0.02 M MOPS running buffer, RNAs were transferred to nitrocellulose membranes (Hybond-C extra, Amersham, Aylesbury, U.K.) by capillary transfer with 10ϫ SSC (1.5 M NaCl, 0.15 M sodium citrate) and fixed at 80ЊC for 2 h. After 4 h of prehybridization at 42ЊC, filters were hybridized with labeled probes (1-4 ϫ; 10 6 cpm/ml) overnight at 42ЊC in 50% formamide, 5ϫ SSPE (0.9 M NaCl, 0.05 M sodium phosphate, 5 mM EDTA pH 7.5; 5ϫ Denhardt solution [1 g Ficoll, 1 g polyvinylpyrroline, 1 g BSA/L], 1% SDS, and 100 g/ml yeast RNA). After this period, membranes were washed four times in 2ϫ SSC/0.1% SDS (20 min at room temperature), followed by 40 min at 55ЊC. Filters were exposed to Kodak X-OMAT (Eastman Kodak, Rochester, NY) films for 1-2 days at Ϫ70ЊC.
Preparation of Total Protein and Western Blot Analysis
Total proteins were extracted from porcine Sertoli cells treated under different conditions. Briefly, Sertoli cells were homogenized in ice-cold hypotonic buffer (25 mM Tris-HCl pH 7.4, 1 mM EDTA, and protease inhibitor cocktail). Homogenized cells were centrifuged at 100 000 ϫ g for 10 min at 4ЊC. Protein concentration was determined in the supernatants using the assay of Bradford [39] with BSA as a standard. Protein extracts (80 g/well) were incubated at 100ЊC for 5 min under reducing conditions, then size-fractionated on SDS/polyacrylamide gel. After electrophoresis, the proteins were transferred at a constant voltage of 100 V for 30 min onto nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) using 10 mM CAPS (pH 11) containing 10% methanol. Following transfer, the membrane was incubated in a blocking buffer (TBS) containing 5% nonfat dry milk at 4ЊC. The membrane was washed with TBS and stained with Ponceau red. After two washes with TBS, the membrane was then incubated with the rabbit polyclonal anti-GST␣ antibody diluted at 1:1000 in a solution of TBS with 0.5% nonfat dry milk for 2 h at room temperature. After washing with TBS, the membrane was then incubated with the goat anti-rabbit peroxidase-conjugated antibody (Jackson Immunoresearch, West Grove, PA) diluted 1:2000 in TBS buffer with 0.5% nonfat dry milk. The antibody-antigen complexes were detected by chemiluminescence using a Pierce detection kit and autoradiographic material from Bio-Rad.
Immunohistochemistry
Paraffin sections of Bouin-fixed testis were cut onto silanized slides. The samples were deparaffinized and rehydrated in PBS. The Ultravision Detection System was used as recommended by the manufacturer. Briefly, endogenous peroxidases were quenched in 3% H 2 O 2 for 15 min. The GST␣ primary antibody was diluted 1:200 in the antibody diluent, and incubated for 2 h at room temperature. After washing, biotinylated goat antipolyvalent secondary antibody was applied and, after washing, a peroxidase-streptavidin complex was applied. Diaminobenzidine was used as the peroxidase chromogen. Sections were briefly counterstained with Harris hematoxylin and mounted in mounting medium.
Negative controls were performed by using, instead of the primary antibody, 1) 0.1% PBS/BSA or 2) nonimmune rabbit serum.
Statistical Analysis
The autoradiographic bands were quantified by densitometric analysis using the Bio Image Scanner (Millipore SA, Saint Quentin, France). Each GST␣ band was normalized by correcting for any variation in the amounts of RNA applied to each lane. Experiments were repeated at least 3 times with different cell preparations. Statistical significance of the results was determined by ANOVA and the Student t-test when data from at least 3 different experiments were compared. Data are presented as the mean Ϯ SD.
RESULTS
Immunolocalization of GST␣ in Postnatal Porcine Testis
Using an immunohistochemical approach, we have identified GST␣ protein in the porcine testis during postnatal development, specifically at 3 critical periods, including 2-3 wk, 3 mo, and 6 mo, which correspond to the neonatal, pubertal, and adult periods, respectively. Whereas GST␣ immunostaining was observed in Leydig cells at the 3 different critical periods in the course of testicular development, it was absent in Sertoli cells at the neonatal period (2-3 wk; Fig. 1 , a and b) but was detectable in these cells at 3 mo (Fig. 1c) and was strongly immunoexpressed in adult (6 mo) Sertoli cells (Fig.  1d) . Germ cells as well as peritubular cells were not stained with GST␣ antibody. These data suggest that GST␣ expression in Sertoli cells appears to be related to the action of gonadotropins, because it was observed at the onset of puberty (i.e., the moment at which FSH and androgens increase in porcine Sertoli cells) [40] . Therefore, in the next series of experiments, we used an in vitro model of cultured porcine Sertoli cells to further characterize the action of FSH and testosterone on GST␣ mRNA and GST␣ protein.
FSH Enhances GST␣ mRNA and Protein Levels
FSH treatment (4.1-1000 ng/ml, 48 h) resulted in a dosedependent increase in GST␣ mRNA levels. The maximal effect of the hormone (3-fold, P Ͻ 0.001) was seen with 111 ng/ml ( Fig. 2A) and the half-maximal (ED 50 ) effect was observed at 18.5 ng/ml FSH. The stimulatory effect of FSH on GST␣ mRNA was also time-dependent. FSH (100 ng/ml) increased GST␣ mRNA levels after 4 h of exposure (P Ͻ 0.001) with a maximal effect after 48 h of exposure (P Ͻ 0.001; Fig. 2B ). 8-Br-cAMP (1 mM, 48 h) treatment increased (P Ͻ 0.001) GST␣ mRNA levels in a comparable manner to FSH (Fig. 2C) . The stimulatory effect of FSH (100 ng/ml, 48 h) on GST␣ mRNA was completely abolished in the presence of cycloheximide (20 g/ml), indicating that the FSH effect on GST␣ mRNA is probably mediated by protein synthesis (Fig. 2D) . The data in Figure  3 show that the stimulatory action of FSH on GST␣ mRNA levels was completely abolished by the protein kinase A (PKA) inhibitor Rp-cAMPS (100 nM). Together, the results in Figures 2C and 3 indicate that FSH increased GST␣ mRNA levels through the PKA/cAMP pathway.
A stimulatory effect of the hormone was also observed on GST␣ protein levels. Indeed, both FSH (100 ng/ml) and 8-Br-cAMP (1 mM) increased GST␣ protein levels as identified by Western blots (Fig. 4) . GST␣ protein is detected as a doublet of 28 kDa.
Testosterone Enhances GST␣ mRNA and Protein Levels
The treatment of Sertoli cells with testosterone (1-62.5 ng/ml, 24 h) resulted in an increase in GST␣ mRNA levels. The maximal (2-fold, P Ͻ 0.002) increase was obtained with 3.9 ng/ml (Fig. 5A) , the half-maximal (ED 50 ) effect being observed with 1.4 ng/ml. Testosterone also stimulated GST␣ mRNA in a time-dependent manner, and the levels of GST␣ mRNA were maximal (2-fold, P Ͻ 0.001) after 8 h of exposure (Fig. 5B) . The antagonistic effect exerted on testosterone-stimulated GST␣ expression by flutamide (3 g/ml), a drug that prevents testosterone binding to its receptor, supports the specificity of the action of the androgen (Fig. 5C) . Furthermore, dihydrotestosterone (DHT), a nonaromatizable androgen (100 ng/ml) increased GST␣ mRNA levels in a nonadditive and comparable manner (Fig. 5D) to that of testosterone, reinforcing the observation that the stimulatory effect of testosterone on GST␣ mRNA levels was exerted via the androgen receptor. However, the possibility that testosterone also exerts its action with its aromatized metabolite, estradiol, remains possible. Indeed, as shown in Figure 6 , estradiol (100 ng/ml, 24 h) was also able to enhance (P Ͻ 0.001) GST␣ mRNA levels. The effects of estradiol and testosterone were additive, suggesting that they use distinct (receptor) signaling pathways. Indeed, the specificity of estradiol action was further confirmed because the stimulatory action of this hormone was completely abolished in the presence of ICI 182,780 (20 M), a specific estrogen receptor antagonist (Fig. 7) .
A stimulatory effect of the steroid hormones was also observed on GST␣ protein levels. Indeed, both testosterone and DHT increased GST␣ protein levels as identified by Western blots (Fig. 8A) . In addition, a conjugate effect of testosterone and estradiol led to a further increase in GST␣ protein levels (Fig. 8B) .
FSH but Not Testosterone Stabilizes GST␣ mRNA
To test the effects of testosterone and FSH on GST␣ mRNA stability, the transcriptional activity in both untreated Sertoli cells (controls), and those treated with testosterone (100 ng/ml, 24 h), DHT (100 ng/ml, 24 h), or estradiol (100 ng/ml, 24 h) was first blocked with 25 M DRB, an inhibitor of transcription, and the levels of GST␣ mRNA were estimated by Northern blot analysis at various times (6, 12, 18 , and 24 h). In the treated Sertoli cells, the decays in GST␣ mRNA levels (half-life time ϭ 24 h) were similar regardless of whether Sertoli cells were or were not treated with testosterone or DHT (Fig. 9A) or with estradiol (Fig.  9B) . In contrast, in FSH or 8-Br-cAMP-treated cells (Fig.  10) , the GST␣ mRNA levels decayed more slowly (halflife time ϭ 113 h) compared with those in untreated cells. In control experiments, there was no significant difference in the rate of degradation of GAPDH mRNA in control and pretreated cells. Taken together, these findings indicate that FSH but not testosterone increased GST␣ mRNA levels by predominantly stabilizing these mRNAs.
Additive Effect of FSH and Testosterone on GST␣ Protein
The treatment of Sertoli cells with FSH and testosterone (100 ng/ml, 24 h) shows an additive effect on GST␣ pro- 24 h A) in the presence or absence of testosterone (100 ng/ml) or DHT (100 ng/ml); or B) with testosterone (100 ng/ ml), estradiol (100 ng/ml), or both. Protein extracts (80 g) were separated on 12% SDS/polyacrylamide gel and transferred onto nitrocellulose and incubated with the polyclonal anti-GST␣ (1:1000). GST␣ protein is evidenced as a doublet of 28 kDa. FIG. 9 . Effect of testosterone, DHT, and estradiol on GST␣ mRNA stability. Sertoli cells were incubated in the absence (□) or presence of A) testosterone (100 ng/ml, 24 h) (ⅷ) or DHT (100 ng/ml, 24 h) (⅜); or B) estradiol (100 ng/ml, 24 h) (Ⅵ) after which 25 M DRB was added to both untreated and treated cells. Total RNA were isolated from control, testosterone-treated, DHT-treated, or estradiol-treated Sertoli cells at 0, 6, 12, 18, and 24 h after the addition of DRB. Ten micrograms of total RNA from each time point were analyzed by Northern blot with radiolabeled GST␣ cDNA probe as described in Materials and Methods. The data are plotted as the percentage of GST␣ mRNA remaining relative to that present at time zero.
tein, confirming that the 2 hormones use distinct stimulatory pathways (Fig. 11) .
DISCUSSION
In the present study we have shown that in the course of postnatal testicular development, GST␣ is expressed in somatic Leydig cells and Sertoli cells, but not in germ cells. In addition, we have found that GST␣ expression in Sertoli cells is under the positive control of FSH and testosterone as well as its 2 metabolites, DHT and estradiol. Indeed, whereas immunoreactive GST␣ has been found also in human testicular Leydig and Sertoli cells [41] , our present results point to a differential developmental regulation of GST␣ expression in both testicular cell types. Indeed, we show that GST␣ is permanently expressed in Leydig cells from the neonatal period to adulthood, whereas in Sertoli cells, GST␣ is absent in the immature testis but not in the adult testis.
Because the maturation process of the male gonad is under gonadotropin control, these observations support the notion that GST␣ expression in Sertoli cells potentially could be induced by testosterone and FSH. Indeed, by using a model of purified Sertoli cells in culture, we have shown that FSH, testosterone per se, and its metabolites, dihydrotestosterone and estradiol, enhance GST␣ mRNA and protein levels. FSH increased GST␣ mRNA and protein levels via the cAMP/PKA pathway as its effects was mimicked by 8-Br-cAMP and abrogated by a PKA inhibitor, RpcAMPs.
Furthermore, although it has been previously reported that FSH enhances GST␣ mRNA levels in granulosa cells [42] , the present data are, to our knowledge, the first to 11 . Additive effects of FSH and testosterone on GST␣ protein levels. Sertoli cells were treated for 24 h with testosterone (100 ng/ml), FSH (100 ng/ml), or both. Protein extracts (80 g) were separated on 12% SDS/polyacrylamide gel, transferred onto nitrocellulose, and incubated with the polyclonal anti-GST␣ (1:1000). GST␣ protein is evidenced as a doublet of 28 kDa.
demonstrate that in Sertoli cells, such a positive action results predominantly from a stabilizing effect of FSH on GST␣ mRNA. However, one cannot exclude the possibility of the existence of an additional transcriptional effect of FSH on GST␣ expression. The mechanisms involved in the stabilizing action of the hormone on GST␣ mRNA are unknown. However, it is of interest to mention that FSH has been shown to stabilize (through the cAMP/PKA pathway) other Sertoli cell mRNAs such as lactate dehydrogenase-A (LDH-A) mRNA [43] . In this context, a 22-bp region called the ''cAMP-stabilizing region'' (1478-1499) in the 3Ј-untranslated region (3Ј-UTR) of LDH-A mRNA, which is targeted by PKA, has been identified in LDH-A mRNA [44] . Because FSH stabilizes GST␣ mRNA, we searched for this sequence in GST␣ mRNA 3Ј-UTR. However, this sequence is not present in GST␣ mRNA. Whether there is another cAMP-stabilizing region in the 3Ј-UTR of GST␣ mRNA requires further investigations.
We report here that testosterone and its metabolites also enhance GST␣ mRNA and protein in Sertoli cells. However, in contrast to FSH, testosterone-stimulated GST␣ mRNA levels were not due to an enhancement in mRNA stabilization, but probably to an increased transcriptional activity. Further studies based, for example, on pulse-chase or the nuclear run-on assays, have to be performed to confirm the direct transcriptional regulatory action by testosterone (and its metabolites) on the gst␣ gene. Also, it is not known whether androgen and estrogen responsive elements are present in the GST␣ promoter, although other different responsive elements including XRE (xenobiotic responsive element, Ϫ908 to Ϫ899), ARE (antioxidant responsive element, Ϫ722 to Ϫ682), and EpRE (electrophilic responsive element, Ϫ754 to Ϫ714) have been identified in the GST promoter [1] . Testosterone appears to be a potent stimulator of GST␣ expression because this steroid hormone exerts its effects both per se and also via its two metabolites, DHT and estradiol. The specificity of the androgen action was supported by the fact that testosterone action was 1) mimicked by the nonaromatizable androgen, DHT, and 2) inhibited by flutamide. The effects of estradiol and testosterone were additive, indicating that these two hormones act through their specific receptors. The abrogation of an estradiol-stimulatory effect on GST␣ expression by a specific estrogen receptor, ICI 183,780, confirmed the specificity of action of this steroid hormone. Testosterone and estradiol have been reported to affect GST activity, particularly in extragonadal tissues [45] . In these studies, GST isoenzymes were characterized in terms of their biological activity and immunoreactivity, but not in terms of specific gene expression of the different GST classes. In contrast to GST action in the testis, testosterone and estradiol have been reported to exert a negative action on GST activity in extragonadal tissues. Indeed, 4 wk of treatment with 17␤-estradiol alone or with 17␤-estradiol plus testosterone propionate promoted a complete loss of immunostaining for ␣ and class GSTs in the epithelial lining of the vas deferens in male golden Syrian hamsters [46] . Such a decrease in GST (specifically of class) following steroid hormone administration appears to be related to hormonal carcinogenesis [47, 48] . However, one should note that these effects are chronic (i.e., for weeks of in vivo treatment) by contrast to those reported in the present study, which are more acute (i.e., 48-72 h in vitro treatment).
In summary, we report here that GST␣ expression in Sertoli cells is targeted by the endocrine system. In a model of primary cultures of Sertoli cells, we have demonstrated that GST␣ expression (mRNA and protein) is dependent on FSH and testosterone action. The two hormones exert their action through distinct pathways. Although testosterone appears to be a potent stimulator of GST␣ expression, acting probably at a transcriptional level per se and via its 2 metabolites, DHT and estradiol, FSH exerts its stimulatory action (via the cAMP/PKA pathway) through an enhancement of GST␣ mRNA stability, although at the present time, a transcriptional effect of the hormone cannot be excluded. Also, the possibility that both FSH and steroid hormones may also act downstream at the protein level (translation/turnover of the protein) cannot be excluded. Taken together, the present observations indicate that Sertoli cell GST␣ is targeted by FSH, testosterone, and its metabolites, and they reinforce the concept that Sertoli cells exert a protective role and are under endocrine control to ward against toxic agents in the context of Sertoli-germ cell interactions during spermatogenesis.
